- Author: Hemang K Pandya, MD; Chief Editor: Hampton Roy, Sr, MD more...
Postoperative endophthalmitis is defined as severe inflammation involving both the anterior and posterior segments of the eye after intraocular surgery. Typically, postoperative endophthalmitis is caused by the perioperative introduction of microbial organisms into the eye either from the patient's normal conjunctival and skin flora or from contaminated instruments. Once organisms gain access to the vitreous cavity, overwhelming inflammation is likely to occur, making rapid recognition, diagnosis, and treatment critical in optimizing final outcomes. Although most cases of postoperative endophthalmitis occur within 6 weeks of surgery, infections seen in high-risk patients or infections caused by slow-growing organisms may occur months or years after the procedure.
The Endophthalmitis Vitrectomy Study (EVS) demonstrated that most isolates causing clinical endophthalmitis are introduced into the eye from the patient's conjunctival flora. However, contamination of sterilized instruments, disposable supplies, prepared solutions, surgical field, or the intraocular lens all have been reported. Epidemic clusters of endophthalmitis have resulted from these types of external contaminations.[2, 3]
Once bacteria are introduced into the eye, risk factors that may increase the risk of endophthalmitis include rupture of the posterior capsule, retained lens material, and surgical procedure. Published studies have demonstrated an increased risk of endophthalmitis after placement of a secondary intraocular lens, possibly due to increased surgical time or ocular manipulation. Prolene haptic sutures also have been implicated as a possible risk factor for the development of endophthalmitis due to the surface properties of the material.
Once clinical infection occurs, damage to ocular tissues is believed to occur due to direct effects of bacterial replication as well as initiation of a fulminant cascade of inflammatory mediators. Endotoxins and other bacterial products appear to cause direct cellular injury while eliciting cytokines that attract neutrophils, which enhance the inflammatory effect. Thus, recent efforts in controlling the damaging effects of endophthalmitis in experimental models have focused on identifying not only appropriate antibiotics for control of the infectious agent but also on anti-inflammatory agents that might disrupt the immunologic events that occur after infection.
Postoperative endophthalmitis remains a rare complication of intraocular surgery. Of the 21,972 patients undergoing cataract extraction at the Bascom Palmer Eye Institute (BPEI) from 1995-2001, 8 (0.04%) developed endophthalmitis. During the same period at BPEI, the incidence of endophthalmitis was 0.2% after secondary intraocular lens (IOL) implantation, 0.03% after pars plana vitrectomy, 0.08% after penetrating keratoplasty, and 0.2% after glaucoma filtering surgery. However, some studies have reported a potentially higher rate of acute endophthalmitis following cataract surgery in recent years, presumably secondary to the adoption of sutureless wounds.[5, 6, 7, 8]
Attention to prophylaxis appears to be the key in reducing the incidence of acute postoperative bacterial endophthalmitis. The requirement by the Bascom Palmer Eye Institute for the use of povidone-iodine prior to surgery played a major role.
The rate of postoperative acute endophthalmitis among developed nations is similar to that of the United States.[10, 11]
Fortunately, postsurgical endophthalmitis, unlike endogenous endophthalmitis, rarely causes any extraocular complications. Rarely, untreated cases can lead to late panophthalmitis and orbital cellulitis, prompting need for enucleation.
Morbidity associated with postoperative endophthalmitis can be substantial and is related not only to the acute process but also to late sequelae. In general, the risk of severe visual loss in patients with acute endophthalmitis is higher in patients who develop infections from more virulent organisms and do not seek treatment promptly.[1, 12, 13] Fortunately, 70-80% of patients with postoperative endophthalmitis have infections caused by coagulase-negative staphylococci, and the visual prognosis in these cases is usually good with rapid treatment.
No racial predilection exists.
No sexual predilection exists.
No age predilection exists.
Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996 Dec. 122(6):830-46. [Medline].
Gibb AP, Fleck BW, Kempton-Smith L. A cluster of deep bacterial infections following eye surgery associated with construction dust. J Hosp Infect. 2006 Jun. 63(2):197-200. [Medline].
Cruciani M, Malena M, Amalfitano G, et al. Molecular epidemiology in a cluster of cases of postoperative Pseudomonas aeruginosa endophthalmitis. Clin Infect Dis. 1998 Feb. 26(2):330-3. [Medline].
Eifrig CW, Flynn HW Jr, Scott IU, et al. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers. 2002 Sep-Oct. 33(5):373-8. [Medline].
Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005 May. 123(5):613-20. [Medline].
West ES, Behrens A, McDonnell PJ, et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology. 2005 Aug. 112(8):1388-94. [Medline].
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007 Jun. 33(6):978-88. [Medline].
Wykoff CC, Parrott MB, Flynn HW Jr, Shi W, Miller D, Alfonso EC. Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002-2009). Am J Ophthalmol. 2010 Sep. 150(3):392-398.e2. [Medline].
Lundström M, Wejde G, Stenevi U, et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology. 2007 May. 114(5):866-70. [Medline].
Ng JQ, Morlet N, Pearman JW, et al. Management and outcomes of postoperative endophthalmitis since the endophthalmitis vitrectomy study: the Endophthalmitis Population Study of Western Australia (EPSWA)'s fifth report. Ophthalmology. 2005 Jul. 112(7):1199-206. [Medline].
Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol. 1995 Dec. 113(12):1479-96. [Medline].
Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007 Jul-Aug. 27(6):662-80. [Medline].
Lalwani GA, Flynn HW Jr, Scott IU, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology. 2008 Mar. 115(3):473-6. [Medline].
Mandelbaum S, Meisler DM. Postoperative chronic microbial endophthalmitis. Int Ophthalmol Clin. 1993 Winter. 33(1):71-9. [Medline].
Clark WL, Kaiser PK, Flynn HW Jr, et al. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology. 1999 Sep. 106(9):1665-70. [Medline]. [Full Text].
Fang YT, Chien LN, Ng YY, et al. Association of hospital and surgeon operation volume with the incidence of postoperative endophthalmitis: Taiwan experience. Eye. 2006 Aug. 20(8):900-7. [Medline].
Maxwell DP Jr, Diamond JG, May DR. Surgical wound defects associated with endophthalmitis. Ophthalmic Surg. 1994 Mar. 25(3):157-61. [Medline].
Kunimoto DY, Kaiser RS. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Ophthalmology. 2007 Dec. 114(12):2133-7. [Medline].
Johnson MW, Doft BH, Kelsey SF, et al. The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997 Feb. 104(2):261-72. [Medline].
Busbee BG, Recchia FM, Kaiser R, et al. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004 Aug. 111(8):1495-503; discussion 1503. [Medline].
Maalouf F, Abdulaal M, Hamam RN. Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes. Int J Inflam. 2012. 2012:313248. [Medline]. [Full Text].
Doft BH, Kelsey SF, Wisniewski SR. Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study. Ophthalmology. 1998 Apr. 105(4):707-16. [Medline].
Holland EJ, McDonald MB, Parekh JG, Sheppard JD. Antibiotic resistance in acute postoperative endophthalmitis. Ophthalmology. 2014 Nov. 121(11 Suppl):S1-9. [Medline].
Park SS, Vallar RV, Hong CH, et al. Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Arch Ophthalmol. 1999 Aug. 117(8):1058-62. [Medline].
Chen JY, Jones MN, Srinivasan S, Neal TJ, Armitage WJ, Kaye SB. Endophthalmitis After Penetrating Keratoplasty. Ophthalmology. 2014 Sep 25. [Medline].
Parke DW 3rd, Pathengay A, Flynn HW Jr, Albini T, Schwartz SG. Risk factors for endophthalmitis and retinal detachment with retained intraocular foreign bodies. J Ophthalmol. 2012. 2012:758526. [Medline]. [Full Text].
Brick DC. Risk management lessons from a review of 168 cataract surgery claims. Surv Ophthalmol. 1999 Jan-Feb. 43(4):356-60. [Medline].